Media
Pop-Science
Novel Potent TIM-3 Inhibitors were discovered in ChemDiv’s collection.
The ChemDiv’s proprietary library of chemically diverse small molecule compounds was demonstrated to be a source of selective inhibitors targeting specific check points was found out in a recen...
ChemDiv in Publications
ChemDiv Company in publications and patents
We are passionate about the latest trends in life sciences and medicinal chemistry and closely monitoring the latest developments and discoveries in this area.
It means a lot to us if our custome...
Pharma News
FDA Grants Breakthrough Therapy to Novartis' Ianalumab for Sjögren's Disease
Novartis receives FDA Breakthrough Therapy tag for ianalumab treating Sjögren's disease after positive Phase III NEPTUNUS results. Filings in 2026.
Follow us: